These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 27997860)

  • 1. VEGF gene therapy cooperatively recruits molecules from the immune system and stimulates cell homing and angiogenesis in refractory angina.
    Eibel B; Markoski MM; Rodrigues CG; Dipp T; de Salles FB; Giusti II; Nardi NB; Plentz RD; Kalil RA
    Cytokine; 2017 Mar; 91():44-50. PubMed ID: 27997860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEGF 165 gene therapy for patients with refractory angina: mobilization of endothelial progenitor cells.
    Rodrigues CG; Plentz RD; Dipp T; Salles FB; Giusti II; Sant'Anna RT; Eibel B; Nesralla IA; Markoski M; Beyer NN; Kalil RA
    Arq Bras Cardiol; 2013 Aug; 101(2):149-53. PubMed ID: 23842797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.
    Yu JX; Huang XF; Lv WM; Ye CS; Peng XZ; Zhang H; Xiao LB; Wang SM
    J Vasc Surg; 2009 Sep; 50(3):608-16. PubMed ID: 19595531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor gene transfer therapy for coronary artery disease: A systematic review and meta-analysis.
    Yuan R; Xin Q; Shi W; Liu W; Lee SM; Hoi P; Li L; Zhao J; Cong W; Chen K
    Cardiovasc Ther; 2018 Oct; 36(5):e12461. PubMed ID: 30035366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic angiogenesis for revascularization in peripheral artery disease.
    Grochot-Przeczek A; Dulak J; Jozkowicz A
    Gene; 2013 Aug; 525(2):220-8. PubMed ID: 23566831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute rise of circulating vascular endothelial growth factor-A in patients with coronary artery disease following cardiothoracic surgery.
    Cotton JM; Mathur A; Hong Y; Brown AS; Martin JF; Erusalimsky JD
    Eur Heart J; 2002 Jun; 23(12):953-9. PubMed ID: 12069450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor-A and platelet-derived growth factor-B combination gene therapy prolongs angiogenic effects via recruitment of interstitial mononuclear cells and paracrine effects rather than improved pericyte coverage of angiogenic vessels.
    Korpisalo P; Karvinen H; Rissanen TT; Kilpijoki J; Marjomäki V; Baluk P; McDonald DM; Cao Y; Eriksson U; Alitalo K; Ylä-Herttuala S
    Circ Res; 2008 Nov; 103(10):1092-9. PubMed ID: 18832750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy.
    Arimura N; Otsuka H; Yamakiri K; Sonoda Y; Nakao S; Noda Y; Hashiguchi T; Maruyama I; Sakamoto T
    Ophthalmology; 2009 May; 116(5):921-6. PubMed ID: 19410951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory cytokine gene variants in coronary artery disease patients in Greece.
    Manginas A; Tsiavou A; Chaidaroglou A; Giamouzis G; Degiannis D; Panagiotakos D; Cokkinos DV
    Coron Artery Dis; 2008 Dec; 19(8):575-82. PubMed ID: 19005292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxysafflor yellow A promotes neovascularization and cardiac function recovery through HO-1/VEGF-A/SDF-1α cascade.
    Wei G; Yin Y; Duan J; Guo C; Zhu Y; Wang Y; Xi M; Wen A
    Biomed Pharmacother; 2017 Apr; 88():409-420. PubMed ID: 28122306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma vascular endothelial growth factor (VEGF) levels after intramuscular and intramyocardial gene transfer of VEGF-1 plasmid DNA.
    Freedman SB; Vale P; Kalka C; Kearney M; Pieczek A; Symes J; Losordo D; Isner JM
    Hum Gene Ther; 2002 Sep; 13(13):1595-603. PubMed ID: 12228014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Puerarin on Clinical Parameters, Vascular Endothelial Function, and Inflammatory Factors in Patients with Coronary Artery Disease.
    Zhang S; Chen L; Zhou Z; Fan W; Liu S
    Med Sci Monit; 2019 Jan; 25():402-408. PubMed ID: 30636768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization.
    Hiasa K; Ishibashi M; Ohtani K; Inoue S; Zhao Q; Kitamoto S; Sata M; Ichiki T; Takeshita A; Egashira K
    Circulation; 2004 May; 109(20):2454-61. PubMed ID: 15148275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1alpha promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion.
    Salven P; Hattori K; Heissig B; Rafii S
    FASEB J; 2002 Sep; 16(11):1471-3. PubMed ID: 12205052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-α-activated mesenchymal stem cells promote endothelial progenitor cell homing and angiogenesis.
    Kwon YW; Heo SC; Jeong GO; Yoon JW; Mo WM; Lee MJ; Jang IH; Kwon SM; Lee JS; Kim JH
    Biochim Biophys Acta; 2013 Dec; 1832(12):2136-44. PubMed ID: 23959047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxic stress simultaneously stimulates vascular endothelial growth factor via hypoxia-inducible factor-1α and inhibits stromal cell-derived factor-1 in human endometrial stromal cells.
    Tsuzuki T; Okada H; Cho H; Tsuji S; Nishigaki A; Yasuda K; Kanzaki H
    Hum Reprod; 2012 Feb; 27(2):523-30. PubMed ID: 22128293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound-targeted gene delivery induces angiogenesis after a myocardial infarction in mice.
    Fujii H; Sun Z; Li SH; Wu J; Fazel S; Weisel RD; Rakowski H; Lindner J; Li RK
    JACC Cardiovasc Imaging; 2009 Jul; 2(7):869-79. PubMed ID: 19608138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide Y Y5-receptor activation on breast cancer cells acts as a paracrine system that stimulates VEGF expression and secretion to promote angiogenesis.
    Medeiros PJ; Jackson DN
    Peptides; 2013 Oct; 48():106-13. PubMed ID: 23932937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose plasmid-mediated VEGF gene transfer is safe in patients with severe ischemic heart disease (Genesis-I). A phase I, open-label, two-year follow-up trial.
    Favaloro L; Diez M; Mendiz O; Janavel GV; Valdivieso L; Ratto R; Garelli G; Salmo F; Criscuolo M; Bercovich A; Crottogini A
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):899-906. PubMed ID: 22777825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.